ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 47, Issue 2, 2006, Pages 245-251

  Vener, Claudia ^a   Gianelli, Umberto ^a   Cortelezzi, Agostino ^a   Fracchiolla, Nicola Stefano ^a   Somalvico, Franco ^a   Savi, Federica ^a   Pasquini, Maria Cristina ^a   Bosari, Silvano ^a   Lambertenghi Deliliers, Giorgio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Chronic lymphocytic leukemia; Immunohistochemistry; ZAP 70 protein

Indexed keywords

ANTILEUKEMIC AGENT; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN KINASE ZAP 70;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPLAN MEIER METHOD; KARYOTYPE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RELIABILITY;

ADULT; AGED; AGED, 80 AND OVER; CYTOGENETIC ANALYSIS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 30644462639     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500272846     Document Type: Article

References (28)

1. Rozman, C and Montserrat, E. (1995) Chronic lymphocytic leukaemia New England Journal of Medicine, 333, pp. 1052 - 1057.
2. Rai, K and Sawitsky, A and Cronkite, E and Chanana, A and Levy, R and Pasternack, B. (1975) Clinical staging of chronic lymphocytic leukaemia Blood, 46, pp. 219 - 234.
3. Binet, J and Auquier, A and Dighiero, G and Chastang, C and Piguet, H and Goasguen, J and (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis Cancer, 48, pp. 198 - 206.
4. Keating, M and Chiorazzi, N and Messmer, B and Damle, R and Allen, S and Rai, K and (2003) Biology and treatment of chronic lymphocytic leukaemia Hematology, pp. 153 - 175.
5. Fais, F and Ghiotto, F and Hashimoto, S and Sellars, B and Valetto, A and Allen, S (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors Journal of Clinical Investigation, 102,pp. 1515 - 1525.
6. Damle, R and Wasil, T and Fais, F and Ghiotto, F and Valetto, A and Allen, S and (1999) IgV gene mutation status and CD 38 expression as novel prognostic indicators in chronic lymphocytic leukaemia Blood, 94, pp. 1840 - 1847.
7. Ritgen, M and Lange, A and Stilgenbauer, S and Dohner, H and Bretscher, C and Bosse, H and (2003) Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukaemia Blood, 101, pp. 2049 - 2053.
8. Wiestner, A and Rosenwald, A and Barry, T and Wright, G and Davis, R and Henrickson, S and (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile Blood, 101, pp. 4944 - 4951.
9. Durig, J and Nuckel, H and Cremer, M and Fhurer, A and Halfmeyer, K and Fandrey, J and (2003) ZAP-70 expression is a prognostic factor in chronic lymphocytic leukaemia Leukemia, 17, pp. 2426 - 2434.
10. Crespo, M and Bosch, F and Villamor, N and Bellosillo, N and Colomer, D and Rozman, M and (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukaemia New England Journal of Medicine, 348, pp. 1764 - 1775.
11. Rai, K and Chiorazzi, N. (2003) Determining the clinical course and outcome in chronic lymphocytic leukaemia New England Journal of Medicine 348, pp. 1797 - 1799.
12. Wagner, S and Cwynarski, K. (2004) Chronic lymphocytic leukemia: New biological markers for assessing prognosis The Hematology Journal, 5, pp. 197 - 201.
13. Mainou-Fowler, T and Dignum, H and Proctor, S and Summerfield, G. (2004) The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (CLL) Leukemia and Lymphoma, 45, pp. 455 - 462.
14. Orchard, J and Ibbotson, R and Davis, Z and Wiestner, A and Rosenwald, A and Thomas, P and (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia Lancet, 363, pp. 105 - 111.
15. Kim, S and Chow, K and Kukoc-Zivojnov, N and Boehrer, S and Brieger, A and Steimle-Grauer, S and (2004) Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status Leukemia and Lymphoma, 45, pp. 2037 - 2045.
16. Rassenti, L and Huynh, L and Toy, T and Chen, L and Keating, M and Gribben, J and (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukaemia New England Journal of Medicine, 351, pp. 893 - 901.
17. Cheson, B and Bennett, J and Grever, M and Kay, N and Keating, M and O'Brien, S and (1996) National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment Blood, 87, pp. 4990 - 4997.
18. Baldini, L and Fracchiolla, N and Cro, L and Trecca, D and Romitti, L and Polli, E and (1994) Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin Blood, 84, pp. 270 - 278.
19. Mitelman, F.(1991) Guidelines for cancer cytogenetics. Supplement to an international system for human cytogenetic nomenclature. Basel: Karger.
20. Klein, U and Tu, Y and Stolovitzky, G and Mattioli, M and Cattoretti, G and Husson, H and (2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells Journal of Experimental Medicine, 194, pp. 1625 - 1638.
21. Rosenwald, A and Alizadeh, A and Widhopf, G and Simon, R and Davis, R and Yu, X and (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukaemia Journal of Experimental Medicine, 194, pp. 1639 - 1647.
22. Rosenwald, A. (2003) DNA microarrays in lymphoid malignancies Oncology, 17, pp. 1743 - 1759.
23. Chen, L and Widhopf, G and Huynh, L and Rassenti, L and Rai, K and Weiss, A and (2002) Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukaemia Blood, 100, pp. 4609 - 4614.
24. Montserrat, E and Sanchez-Bisono, J and Vinolas, N and Rozman, C. (1986) Lymphocyte doubling time in chronic lymphocytic leukaemia: Analysis of its prognostic significance British Journal of Haematology, 62, pp. 567 - 575.
25. Admirand, J and Rassidakis, G and Abruzzo, L and Valbuena, J and Jones, D and Jeffrey Medeiros, L. (2004) Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma Modern Pathology 17, pp. 954 - 961.
26. Sup, S and Domiati-Saad, R and Kelley, T and Steinle, R and Zhao, X and His, E. (2004) ZAP-70 expression in B-Cell hematologic malignancy is not limited to CLL/SLL American Journal of Clinical Pathology, 122, pp. 582 - 587.
27. Lewis, F and Jackson, P and Lane, S and Coast, G and Hanby, A. (2004) Testing for HER2 in breast cancer Histopathology, 45, pp. 207 - 217.
28. Yano, S and Kondo, K and Yamaguchi, M and Richmond, G and Hutchison, M and Wakeling, A and (2003) Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition Anticancer Research, 23, pp. 3639 - 3650.